What the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.64%Below 5Y avg (2.34%)
Annual Rate
USD 0.04Paid quarterly
Payout Ratio
31.3%Sustainable
Paying Dividends
5 yr
Last Ex-Dividend
Aug 27, 2026
Last Payment
Sep 15, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
355.26MUSD
185.70M · vs all stocks (USD)
Updated Oct 18, 2026
Trailing P/E
4.27x
vs Medical Instruments & Supplies peers
Updated Oct 18, 2026
Revenue (TTM)
1.02BUSD
1.04B · vs all stocks (USD)
Updated Oct 18, 2026
Profit Margin
8.59%
vs Medical Instruments & Supplies peers
Updated Oct 18, 2026
Beta
0.8310x
vs all stocks
Updated Oct 18, 2026
52-Week Change
-55.53%
vs all stocks
Updated Oct 18, 2026
Forward Annual Dividend Yield
0.64%
vs all stocks
Updated Oct 18, 2026
Market Capitalization
355.26MUSD
185.70M · vs all stocks (USD)
Updated Oct 18, 2026
Enterprise Value
1.64BUSD
1.37B · vs all stocks (USD)
Updated Oct 18, 2026
Trailing P/E
4.27x
vs Medical Instruments & Supplies peers
Updated Oct 18, 2026
Forward P/E
3.56x
vs Medical Instruments & Supplies peers
Updated Oct 18, 2026
PEG Ratio
-0.0792x
vs Medical Instruments & Supplies peers
Updated Oct 18, 2026
Price to Sales (TTM)
0.3487x
vs Medical Instruments & Supplies peers
Updated Oct 18, 2026
Enterprise to Revenue
1.61x
vs Medical Instruments & Supplies peers
Updated Oct 18, 2026
Enterprise to EBITDA
5.83x
vs Medical Instruments & Supplies peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 5.66×.Updated Oct 18, 2026
Gross Margin
56.42%
vs Medical Instruments & Supplies peers
Updated Oct 18, 2026
Profit Margin
8.59%
vs Medical Instruments & Supplies peers
Updated Oct 18, 2026
Operating Margin
23.67%
vs Medical Instruments & Supplies peers
Updated Oct 18, 2026
Return on Assets (TTM)
12.24%
vs Medical Instruments & Supplies peers
Updated Oct 18, 2026
Revenue (TTM)
1.02BUSD
1.04B · vs all stocks (USD)
Updated Oct 18, 2026
Revenue per Share (TTM)
17.33USDUpdated Oct 18, 2026
Quarterly Revenue Growth
-8.10%
vs Medical Instruments & Supplies peers
Updated Oct 18, 2026
Gross Profit (TTM)
595.10MUSD
645.50M · vs all stocks (USD)
Updated Oct 18, 2026
EBITDA (TTM)
290.20MUSD
331.50M · vs all stocks (USD)
Updated Oct 18, 2026
Net Income (TTM)
87.50MUSD
111.90M · vs all stocks (USD)
Updated Oct 18, 2026
Quarterly Earnings Growth (YoY)
-53.60%
vs Medical Instruments & Supplies peers
Updated Oct 18, 2026
Operating Cash Flow (TTM)
174.10MUSD
213.50M · vs all stocks (USD)
Updated Oct 18, 2026
Levered Free Cash Flow (TTM)
138.20MUSD
195.80M · vs all stocks (USD)
Updated Oct 18, 2026
Forward Annual Dividend Rate
0.0400USDUpdated Oct 18, 2026
Forward Annual Dividend Yield
0.64%
vs all stocks
Updated Oct 18, 2026
Trailing Annual Dividend Rate
0.3200USDUpdated Oct 18, 2026
Trailing Annual Dividend Yield
5.10%
vs all stocks
Updated Oct 18, 2026
5-Year Average Dividend Yield
2.34%
vs all stocks
Updated Oct 18, 2026
Payout Ratio
31.29%
vs Medical Instruments & Supplies peers
Provider-reported. Trailing Annual Dividend Rate ÷ Diluted EPS (TTM) on this page gives 21.77%.Updated Oct 18, 2026
Revenue
1.08BUSDFY2025 · Sep 30, 2025
Cost of Goods Sold
403.60MUSDFY2025 · Sep 30, 2025
Gross Profit
676.80MUSDFY2025 · Sep 30, 2025
Operating Income
296.40MUSD
vs all stocks (USD)
FY2025 · Sep 30, 2025
Pre-tax Income
136.30MUSDFY2025 · Sep 30, 2025
Income Tax Expense
40.90MUSDFY2025 · Sep 30, 2025
Net Income
95.40MUSDFY2025 · Sep 30, 2025
EBIT
243.60MUSDFY2025 · Sep 30, 2025
EBITDA (Income Statement)
338.60MUSDFY2025 · Sep 30, 2025
Research & Development
37.30MUSDFY2025 · Sep 30, 2025
Selling, General & Administrative
332.00MUSDFY2025 · Sep 30, 2025
Other Operating Expenses
700.00KUSDFY2025 · Sep 30, 2025
Non-operating Interest Expense
107.30MUSDFY2025 · Sep 30, 2025
EPS (Basic)
1.64USDFY2025 · Sep 30, 2025
EPS (Diluted)
1.62USDFY2025 · Sep 30, 2025
Basic Shares Outstanding
58.17MSharesFY2025 · Sep 30, 2025
Diluted Shares Outstanding
58.17MSharesFY2025 · Sep 30, 2025
Net Income from Continuing Operations
95.40MUSDFY2025 · Sep 30, 2025
Operating Cash Flow
200.70MUSDFY2025 · Sep 30, 2025
Cash & Cash Equivalents (End of Period)
228.60MUSDFY2025 · Sep 30, 2025
Income Tax Paid
50.10MUSDFY2025 · Sep 30, 2025
Interest Paid
103.80MUSDFY2025 · Sep 30, 2025
Starting Profit (CF Statement)
95.40MUSDFY2025 · Sep 30, 2025
Depreciation & Amortization
40.70MUSDFY2025 · Sep 30, 2025
Deferred Taxes (CF)
17.60MUSDFY2025 · Sep 30, 2025
Stock-based Compensation
31.60MUSDFY2025 · Sep 30, 2025
Other Non-cash Items
19.50MUSDFY2025 · Sep 30, 2025
Change in Accounts Receivable (CF)
44.20MUSDFY2025 · Sep 30, 2025
Change in Accounts Payable (CF)
-68.90MUSDFY2025 · Sep 30, 2025
Change in Other Assets/Liabilities
20.60MUSDFY2025 · Sep 30, 2025
Long-term Debt Payments
-186.00MUSDFY2025 · Sep 30, 2025
Common Dividends Paid
-35.00MUSDFY2025 · Sep 30, 2025
Other Financing Charges
-5.70MUSDFY2025 · Sep 30, 2025
Net Financing Cash Flow
-226.70MUSDFY2025 · Sep 30, 2025
Shares Outstanding
56.66MSharesUpdated Oct 18, 2026
Float Shares
54.77MSharesUpdated Oct 18, 2026
Shares Short
5.83MSharesUpdated Oct 18, 2026
Short Ratio
4.70days
vs all stocks
Updated Oct 18, 2026
Short % of Shares Outstanding
12.36%
vs all stocks
Provider-reported. Shares Short ÷ Shares Outstanding on this page gives 10.28%.Updated Oct 18, 2026
% Held by Insiders
2.01%
vs all stocks
Updated Oct 18, 2026
% Held by Institutions
91.46%
vs all stocks
Updated Oct 18, 2026
Total Cash (MRQ)
214.70MUSD
184.90M · vs all stocks (USD)
Updated Oct 18, 2026
Total Cash per Share (MRQ)
3.79USDUpdated Oct 18, 2026
Total Debt (MRQ)
1.50BUSD
1.37B · vs all stocks (USD)
Updated Oct 18, 2026
Current Ratio (MRQ)
1.68x
vs Medical Instruments & Supplies peers
Updated Oct 18, 2026
Book Value per Share (MRQ)
-10.81USDUpdated Oct 18, 2026
Total Assets
1.09BUSD
vs all stocks (USD)
FY2025 · Sep 30, 2025
Total Current Assets
631.40MUSDFY2025 · Sep 30, 2025
Total Liabilities
1.74BUSDFY2025 · Sep 30, 2025
Total Non-current Assets
459.50MUSDFY2025 · Sep 30, 2025
Total Non-current Liabilities
1.48BUSDFY2025 · Sep 30, 2025
Total Current Liabilities
261.50MUSDFY2025 · Sep 30, 2025
Cash & Cash Equivalents
225.50MUSDFY2025 · Sep 30, 2025
Accounts Receivable
145.60MUSDFY2025 · Sep 30, 2025
Inventory
178.60MUSDFY2025 · Sep 30, 2025
Accounts Payable
74.20MUSDFY2025 · Sep 30, 2025
Short-term Debt
12.90MUSDFY2025 · Sep 30, 2025
Long-term Debt
1.42BUSDFY2025 · Sep 30, 2025
Other Non-current Liabilities
63.20MUSDFY2025 · Sep 30, 2025
Common Stock (Book)
0.00USDFY2025 · Sep 30, 2025
Retained Earnings
-445.60MUSDFY2025 · Sep 30, 2025
Total Shareholders' Equity
-651.20MUSD
vs all stocks (USD)
FY2025 · Sep 30, 2025
52-Week Low
2.77USDUpdated Oct 18, 2026
52-Week High
14.91USDUpdated Oct 18, 2026
52-Week Change
-55.53%
vs all stocks
Updated Oct 18, 2026
Beta
0.8310x
vs all stocks
Updated Oct 18, 2026
50-Day MA
5.43USDUpdated Oct 18, 2026
200-Day MA
6.73USDUpdated Oct 18, 2026
Avg 10-Day Volume
901.10KSharesUpdated Oct 18, 2026
Avg 30-Day Volume
1.04MSharesUpdated Oct 18, 2026
Diluted EPS (TTM)
1.47USDUpdated Oct 18, 2026
Other Income / Expense
-52.80MUSDFY2025 · Sep 30, 2025
2 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
The price sits below its 40-week average, on three profitable years and cash above profit.
Reads
Price Below Mean With Profitability And Book Value
Price sits well below its yearly mean, on three profitable years and rising book value.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Return on assets is 16.8%, higher than 95% of its Medical Instruments & Supplies peers (median 4.8%)Significant
Return on assets: 0.17Industry median: 0.05Industry P95: 0.13Peers compared: 57.00
P/E ratio is 1.63×, lower than 95% of its Medical Instruments & Supplies peers (median 29.53×)Notable